key: cord-0872912-c73if3of
authors: Birben, Birkan; Birben, Ozlem Duvenci; Akın, Tezcan; Akkurt, Gokhan; Surel, Aziz Ahmet; Yakısık, Esra; Erdem, Deniz
title: Efficacy of the delta neutrophil index in predicting 30‐day mortality in COVID‐19 patients requiring intensive care
date: 2021-01-06
journal: Int J Clin Pract
DOI: 10.1111/ijcp.13970
sha: 502ed85b0a73d59dbccf70bf9edf23201efe885f
doc_id: 872912
cord_uid: c73if3of

OBJECTIVES: Coronavirus‐19 is a rapidly progressing disease that can result in mortality. We aimed to evaluate the efficacy of the delta neutrophil index in predicting mortality in intensive care patients diagnosed with Coronavirus‐19. MATERIALS AND METHODS: Patients with a positive polymerase chain reaction test and/or computed tomography findings compatible with the disease were included in the study. The demographic characteristics of the patients, polymerase chain reaction test results, chest computed tomography findings, blood parameters at the time of presentation, 30‐day mortality, and the number of days in the intensive care unit were assessed. RESULTS: Of the 388 patients receiving intensive care, 220 (56.7%) were men and 168 (43.3%) were women. The mean age was 70 ± 15 years. The evaluation of mortality, 264 (68%) of the patients survived and 124 (32%) died. The delta neutrophil index, neutrophil lymphocyte ratio, lactate, interleukin‐6 and C‐reactive protein values were statistically significantly higher and the lymphocyte value was significantly lower in the mortality group (P = .003, .034, .000, .002, .000 and .024, respectively). In the receiver operating characteristic curve analysis, the area under the curve values of the delta neutrophil index, lymphocyte, neutrophil lymphocyte ratio, lactate, interleukin‐6 and C‐reactive protein levels in predicting mortality were 0.718, 0.416, 0.628, 0.585, 0.701 and 0.684, respectively. CONCLUSION: We consider that the delta neutrophil index can be used as an effective prognostic parameter to show intensive care mortality in patients with Coronavirus‐19.

to evaluate the efficacy of DNI in predicting mortality in intensive care patients diagnosed with COVID-19 based on PCR and/or chest CT. were included in the study. Patients whose CT findings were not compatible with COVID-19 and PCR test was negative, those with haematological malignancies and pregnant women were excluded.

The demographic characteristics of the patients, COVID-19 PCR test results, chest CT findings, blood parameters at the time of presentation to the emergency service or transfer from this service to the intensive care unit (procalcitonin, delta neutrophil index, leukocyte, platelet count, lymphocyte, neutrophil lymphocyte ratio, RDW, blood lactate level, interleukin-6 and CRP values), 30-day mortality and the number of days in the intensive care unit were evaluated. At least one positive value was considered significant in the PCR test.

The patients were evaluated in two groups as those who died in intensive care (mortality group) and those who recovered (surviving group).

Data analysis was carried out using SPSS for Windows program v. 15 . Normality was assessed using the Kolmogorov-Smirnov test.

The descriptive statistics of normally distributed continuous variables were expressed as mean ± standard deviation (SD) while those of non-normally distributed continuous variables were given as median (interquartile range) values. The differences between the groups in terms of normally distributed variables were analysed with the Student's t-test while non-normally distributed variables were analysed using the Mann-Whitney U test. The discriminative power of variables was measured as the area under the receiver operating characteristic (ROC) curve. The discriminative power of the prognostic variables was considered perfect if the area under the curve (AUC) was 1, good if >0.8, moderate if 0.6-0.8 and poor if <0.6. Specificity, sensitivity, positive predictive value (PPV), negative predictive value (NPV), negative likelihood ratio and positive likelihood ratio were also calculated.

Of the 388 patients hospitalised in intensive care, 220 (56.7%) were men and 168 (43.3%) were women. The mean age of the patients suspicion on a chest CT as 5 (4%). The median value for the number of days in the intensive care unit was 5 (3) (4) (5) (6) (7) (8) (9) (10) (11) .

When the blood parameters were compared between the mortality and surviving groups for the first 30 days of intensive care, it was observed that the mean age was higher in the mortality group, but there was no statistically significant difference (P = .182). The procalcitonin, RDW and leukocyte values were also found to be higher among the patients in the mortality group without a statistically significant difference (P = .243, .075 and .498 respectively). The platelet value was lower in the mortality group with no statistical significance (P = .058). The DNI, lactate, interleukin-6, CRP and NLR values were significantly higher (P = .003, .000, .002, .000 and .034, respectively) and the lymphocyte value was significantly lower (P = .024) in the mortality group compared to the surviving group. It was observed that the percentage of patients with suspected COVID-19 on a chest CT was higher in the mortality group, but there was no statistically significant difference (P = .081). However, the number of hospitalised days in the intensive care unit was significantly lower in the mortality group (P = .027) ( Table 1 ).

In the ROC analysis (Figure 1) 

Simple laboratory parameters are more useful in predicting patient prognosis, so they are used more commonly in daily medical practice. 4 Frater et al stated that the procalcitonin value was mostly in the normal range in the early stages of COVID-19, but increased in cases where the severity of infection increased. 6 In our study, although the procalcitonin value was elevated on the first day of intensive care, this was not statistically significant, suggesting that it is a parameter to be evaluated according to consecutive daily changes rather 17 In our study, DNI was found to be significantly higher in the mortality group. We consider that the association of high DNI with mortality may be related to ARDS. Predicting the mortality in Covid-19 patients is important for regulating patients' treatment. Scoring systems which are formed by using these parameters could be extremely useful for determining the high-risk patient groups. 18 In conclusion, we consider that DNI can be used as an effective prognostic parameter to show intensive care mortality in COVID-19

patients. There is a need for further research in this area, especially in terms of determining cases that will progress in intensive care.

All authors declare that there is no conflict of interest.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

https://orcid.org/0000-0001-7165-8246

Gokhan Akkurt https://orcid.org/0000-0002-0908-4226

Aziz Ahmet Surel https://orcid.org/0000-0002-4992-1754

World Health Organization. WHO coronavirus disease (COVID-19) Dashboard. Data last

Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review

Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis

To study the role of absolute lymphocyte count and RDW in COVID 19 patients and their association with appearance of symptoms and severity

COVID-19 and the clinical hematology laboratory

Delta neutrophil index as an early predictor of acute appendicitis and acute complicated appendicitis in adults

The delta neutrophil index (DNI) as a prognostic marker for mortality in adults with sepsis: a systematic review and meta-analysis

The delta neutrophil index predicts development of multiple organ dysfunction syndrome and 30-day mortality in trauma patients admitted to an intensive care unit: a retrospective analysis

D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

An increased neutrophil/ lymphocyte ratio is an early warning signal of severe COVID-19. Nan fang yi ke da xue xue bao=

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis

Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19

Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management

Sensitivity of chest CT for COVID-19: comparison to RT-PCR

Overview: systemic inflammatory response derived from lung injury caused by SARS-CoV-2 infection explains severe outcomes in COVID-19

Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19

Efficacy of the delta neutrophil index in predicting 30-day mortality in COVID-19 patients requiring intensive care